Medirom Healthcare Technologies Inc. (MRM) stock
MRMNasdaqServices-Personal ServicesFiscal year ends December 31
Financials through fiscal 2024, year ended Dec 31, 2024
$0.28+0.01 (+2.46%)
Close on Nov 12, 2026Market cap $2.24MP/E 1.6Yield –
Medirom Healthcare Technologies statistics
89 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2025
- Share price as of
- –
Valuation ratiosIndustry
Enterprise valuationIndustry
- EV / Sales
- 0.28
- –
Share statisticsIndustry
- Shares Change (YoY)
- 13.3%
- –
- Float
- 6M
- –
- Shares Held by Insiders
- 27.0%
- –
- Shares Held by Institutions
- 2.17%
- –
Short sellingIndustry
- Short Interest
- 9,002
- –
- Short Interest Change
- -69.9%
- –
- Days to Cover
- 1.00
- –
Stock price statisticsIndustry
- Price Change (1 Week)
- -1.70%
- –
- Price Change (1 Month)
- -15.6%
- –
- Price Change (3 Months)
- -73.5%
- –
- Price Change (6 Months)
- -68.8%
- –
- Price Change (YTD)
- -85.4%
- –
- Price Change (1 Year)
- -86.3%
- –
- Price Change (3 Years)
- -94.3%
- –
- Price Change (5 Years)
- -96.2%
- –
- Average Volume (10 Days)
- 21,566
- –
- Average Volume (20 Days)
- 46,646
- –
- Average Volume (90 Days)
- 108,271
- –
- Relative Volume
- 0.08
- –
- Relative Strength Index (14)
- 26.0
- –
- Volatility (1 Year)
- 73.8%
- –
- Beta (5 Years)
- 0.61
- –
MarginsIndustry
- Pretax Margin
- 0.57%
- –
- EBITDA Margin
- 3.28%
- –
- FCF Margin
- -16.9%
- –
Returns on capitalIndustry
- Return on Equity (ROE)
- 61.3%
- –
- Return on Assets (ROA)
- 1.86%
- –
- Return on Invested Capital (ROIC)
- -0.83%
- –
- Return on Capital Employed (ROCE)
- -0.60%
- –
Financial positionIndustry
- Current Ratio
- 0.24
- –
- Quick Ratio
- 0.05
- –
- Debt / Equity
- 8.11
- –
- Debt / EBITDA
- 7.24
- –
- Net Debt / EBITDA
- 7.10
- –
- Interest Coverage
- -0.36
- –
GrowthIndustry
- Revenue Growth (YoY)
- 21.5%
- –
- Net Income Growth (YoY)
- 28.9%
- –
- EPS Growth (YoY)
- 27.7%
- –
- Revenue Growth (3Y CAGR)
- 15.3%
- –
- Revenue Growth (5Y CAGR)
- 16.3%
- –
- EPS Growth (5Y CAGR)
- 47.7%
- –
EfficiencyIndustry
- Asset Turnover
- 1.04
- –
- Inventory Turnover
- 34.56
- –
- Revenue Per Employee
- ¥24.85M
- –
- Profits Per Employee
- ¥445.40K
- –
- Employee Count
- 334
- –
- WACC
- 5.34%
- –
Income statement (TTM)Industry
- Pretax Income
- ¥47.71M
- –
Balance sheetIndustry
- Net Cash (Debt)
- -¥1.93B
- –
- Net Cash Per Share
- -244.40 JPY
- –
- Equity (Book Value)
- ¥242.80M
- –
- Book Value Per Share
- 30.73 JPY
- –
- Tangible Book Value
- -¥132.59M
- –
- Working Capital
- -¥3.77B
- –
Cash flow (TTM)Industry
- Capital Expenditures
- -¥71.41M
- –
- FCF Per Share
- -177.56 JPY
- –
Dividends and yieldsIndustry
- Earnings Yield
- 42.0%
- –
- FCF Yield
- -395.7%
- –
Taxes and interestIndustry
- Interest Expense
- ¥49.75M
- –
- Income Tax
- -¥90.48M
- –
- Effective Tax Rate
- -189.6%
- –
Scores and fair valueIndustry
- Graham Number
- 140.42 JPY
- –
- Graham Upside
- 212.9%
- –
- Altman Z-Score
- 0.41
- –
- Piotroski F-Score
- 6
- –
- Beneish M-Score
- -0.80
- –
- Lynch Fair Value
- 713.00 JPY
- –
- Lynch Upside
- 1488.9%
- –
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | MRM | S&P 500 | Difference | MRM per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -47.2% | -2.7% | −44.5 pts | ||
| 3 months | -72.2% | -1.7% | −70.4 pts | ||
| Year to date | -85.4% | +11.9% | −97.3 pts | ||
| 1 year | -86.5% | +12.0% | −98.5 pts | ||
| 3 years | -94.2% | +78.2% | −172.4 pts | -61.3% | +21.2% |
| 5 years | -96.2% | +73.2% | −169.4 pts | -47.9% | +11.6% |
| 10 years | -98.2% | +309.6% | −407.9 pts | -33.2% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
0M MRM shares were sold short on Oct 30, 2026, down 69.9% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 44.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 9,002 | -69.9% | 65,435 | 1.0 |
| Oct 15, 2026 | 29,941 | +977.4% | 656,382 | 1.0 |
| Sep 30, 2026 | 2,779 | -78.6% | 20,358 | 1.0 |
| Sep 15, 2026 | 13,001 | -28.1% | 6,768 | 1.9 |
| Aug 31, 2026 | 18,094 | -34.4% | 37,070 | 1.0 |
| Aug 14, 2026 | 27,597 | -25.5% | 71,146 | 1.0 |
| Jul 31, 2026 | 37,052 | -47.9% | 8,508 | 4.3 |
| Jul 15, 2026 | 71,107 | -29.3% | 11,236 | 6.3 |
| Jun 30, 2026 | 100,574 | -26.2% | 123,131 | 1.0 |
| Jun 15, 2026 | 136,211 | -59.8% | 68,176 | 2.0 |
| May 29, 2026 | 338,625 | +438.9% | 2,199,028 | 1.0 |
| May 15, 2026 | 62,840 | -30.0% | 32,210 | 1.9 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?